Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion type Assertion NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_head.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion evidence source_evidence_literature NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion SIO_000772 11423472 NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion wasDerivedFrom befree-2016 NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.
- NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion wasGeneratedBy ECO_0000203 NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.